AI assistant
Merck & Co., Inc. — Director's Dealing 2023
Dec 13, 2023
284_dirs_2023-12-13_020f672b-6d8e-4c00-bada-67571f76052f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-12-04
Reporting Person: Smart Dalton (SVP Fin. - Global Controller)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6.245 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2026-05-02 | Common Stock (1145) | Direct | |
| Restricted Stock Unit | $ | 2025-05-03 | Common Stock (1034) | Direct | |
| Restricted Stock Unit | $ | 2025-05-03 | Common Stock (3062) | Direct | |
| Restricted Stock Unit | $ | 2024-05-04 | Common Stock (612) | Direct | |
| Stock Option (Right to Buy) | $58.08 | 2025-04-30 | Common Stock (5000) | Direct | |
| Stock Option (Right to Buy) | $62.07 | 2027-05-04 | Common Stock (12130) | Direct | |
| Stock Option (Right to Buy) | $56.04 | 2028-05-03 | Common Stock (12447) | Direct | |
| Stock Option (Right to Buy) | $77.62 | 2029-05-02 | Common Stock (9600) | Direct | |
| Stock Option (Right to Buy) | $75.36 | 2030-04-30 | Common Stock (13542) | Direct | |
| Stock Option (Right to Buy) | $73.73 | 2031-05-03 | Common Stock (14198) | Direct | |
| Stock Option (Right to Buy) | $87.10 | 2032-05-02 | Common Stock (8738) | Direct | |
| Stock Option (Right to Buy) | $117.89 | 2033-05-01 | Common Stock (6224) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in two equal installments on 5/3/2024 and 5/3/2025.
F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock on 5/4/2024.
F6: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
F7: The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
F8: The option became exercisable in equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F9: The option became exercisable in equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
F10: The option became exercisable in equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
F11: The option vests and becomes exercisable in equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F12: The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
F13: The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.